TRPM7 and diabetic kidney disease: When comparing the two kidney nephropathy models, we propose that CBGA-induced inhibition of TRPM7 may progressively shift its impact on different target cell populations depending on the stage of progressive kidney damage: In the acute stage of nephropathy, the damage will mostly involve tubular epithelial cells, whereas the late stage will mainly involve progressive renal fibrosis.